Search reports, ask a question, or jump to a page.
The problem
Intervention: Higher-intensity, weight-based ready-to-use therapeutic food (RUTF) combined with hydroxyurea medication
Who it was tested with: Children aged 5-12 years with sickle cell anemia and severe malnutrition (BMI z-score below -3.0) after 12 weeks of initial RUTF treatment.
The same group is measured before the intervention and again afterwards, with a baseline and an endline and sometimes a midline. Change is visible, but other causes cannot be ruled out.
"a prognostic signal that warrants prospective testing rather than an immediate change in practice" - the authors themselves note this is a single-arm study identifying a prognostic pattern, not a controlled test of treatment effectiveness.
Single-arm design without a comparison group means it cannot confirm the treatment caused the improvement; small sample size limits generalizability.
Across countries and designs
1 study · 1 country
